blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1787999

EP1787999 - Anti-VEGF antibodies [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.06.2011
Database last updated on 17.05.2024
Most recent event   Tooltip10.06.2011No opposition filed within time limitpublished on 13.07.2011  [2011/28]
Applicant(s)For all designated states
Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080-4990 / US
[N/P]
Former [2008/38]For all designated states
Genentech, Inc.
1 DNA Way
South San Francisco CA 94080-4990 / US
Former [2007/21]For all designated states
Genentech, Inc.
1 DNA Way
South San Francisco CA 94080-4990 / US
Inventor(s)01 / Baca, Manuel
c/o The Walter & Eliza Hall Inst. of Med. Research, 1G Royal Parade
Parkville, Victoria 3050 / AU
02 / Presta, Leonard G.
Apartment 206, 1900 Gough, Apt. 206
San Francisco, California 94109 / US
03 / Wells, James A.
1341 Columbus Avenue
Burlingame, California 94010 / US
04 / Lowman, Henry B.
400 San Juan Avenue
El Granada, California 94018 / US
05 / Chen, Yvonne Man-Yee
1951 O'Farrell Street, Apt. 321
San Mateo, California 94403 / US
 [2010/31]
Former [2007/51]01 / Baca, Manuel
c/o The Walter & Eliza Hall Inst. of Med. Research 1G Royal Parade
Parkville, Victoria 3050 / AU
02 / Presta, Leonard G.
Apartment 206, 1900 Gough, Apt. 206
San Francisco, California 94109 / US
03 / Wells, James A.
1341 Columbus Avenue
Burlingame, California 94010 / US
04 / Lowman, Henry B.
400 San Juan Avenue
El Granada, California 94018 / US
05 / Chen, Yvonne Man-Yee
1951 O'Farrell Street, Apt. 321
San Mateo, California 94403 / US
Former [2007/21]01 / Baca, Manuel
c/o The Walter & Eliza Hall Inst. of Med. Research Post Office, Royal Melbourne Hospital
Victoria 3050 / AU
02 / Presta, Leonard G.
Apartment 206, 1900 Gough, Apt. 206
San Francisco, California 94109 / US
03 / Wells, James A.
1341 Columbus Avenue
Burlingame, California 94010 / US
04 / Lowman, Henry B.
400 San Juan Avenue
El Granada, California 94018 / US
05 / Chen, Yvonne Man-Yee
1951 O'Farrell Street, Apt. 321
San Mateo, California 94403 / US
Representative(s)Denison, Christopher Marcus, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[N/P]
Former [2007/21]Denison, Christopher Marcus, et al
Mewburn Ellis LLP York House 23 Kingsway
London WC2B 6HP / GB
Application number, filing date06024703.803.04.1998
[2007/21]
Priority number, dateUS1997083350407.04.1997         Original published format: US 833504
US1997090846906.08.1997         Original published format: US 908469
[2007/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1787999
Date:23.05.2007
Language:EN
[2007/21]
Type: B1 Patent specification 
No.:EP1787999
Date:04.08.2010
Language:EN
[2010/31]
Search report(s)(Supplementary) European search report - dispatched on:EP16.04.2007
ClassificationIPC:G01N33/68, C07K16/22
[2010/08]
CPC:
C07K16/22 (EP,KR,US); A61K39/00 (KR); A61P25/00 (EP);
A61P27/02 (EP); A61P35/00 (EP); C07K16/005 (EP,US);
A61K38/00 (EP,US); C07K2317/24 (EP,US); C07K2317/55 (EP,US);
C07K2317/56 (EP,US); C07K2317/565 (EP,US); C07K2317/569 (EP,US);
C07K2317/73 (EP,US); C07K2317/92 (EP,US) (-)
Former IPC [2007/21]C07K16/22, C12N15/13, C12N15/63, C12N15/70, A61K39/395
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2008/17]
Former [2008/05]
Former [2007/21]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE 
Extension statesAL13.03.2008
LT13.03.2008
LV13.03.2008
MK13.03.2008
RO13.03.2008
SI13.03.2008
TitleGerman:Anti-VEGF Antikörper[2007/21]
English:Anti-VEGF antibodies[2007/21]
French:Anti-VEGF anticorps[2007/21]
Examination procedure13.03.2008Examination requested  [2008/17]
10.04.2008Despatch of a communication from the examining division (Time limit: M06)
05.02.2009Reply to a communication from the examining division
24.02.2009Despatch of a communication from the examining division (Time limit: M06)
13.10.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
21.12.2009Reply to a communication from the examining division
17.02.2010Communication of intention to grant the patent
01.06.2010Fee for grant paid
01.06.2010Fee for publishing/printing paid
Parent application(s)   TooltipEP98917991.6  / EP0973804
Divisional application(s)EP10007444.2  / EP2301580
EP10010132.8  / EP2338915
EP10181127.1  / EP2336190
EP16181733.3
Opposition(s)06.05.2011No opposition filed within time limit [2011/28]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
05.02.2009Request for further processing filed
05.02.2009Full payment received (date of receipt of payment)
Request granted
19.02.2009Decision despatched
Extension request deemed withdrawn in respect of
SI, RO, MK, LV, LT, AL
13.03.2008Request for further processing filed
13.03.2008Full payment received (date of receipt of payment)
Request granted
28.03.2008Decision despatched
The application is deemed to be withdrawn due to non-payment of the examination fee
13.03.2008Request for further processing filed
13.03.2008Full payment received (date of receipt of payment)
Request granted
28.03.2008Decision despatched
The application is deemed to be withdrawn due to non-payment of designation fees
SE, PT, NL, MC, LU, IT, IE, GR, GB, FR, FI, ES, DK, DE, CY, CH, BE, AT
13.03.2008Request for further processing filed
13.03.2008Full payment received (date of receipt of payment)
Request granted
28.03.2008Decision despatched
Fees paidRenewal fee
18.12.2006Renewal fee patent year 03
18.12.2006Renewal fee patent year 04
18.12.2006Renewal fee patent year 05
18.12.2006Renewal fee patent year 06
18.12.2006Renewal fee patent year 07
18.12.2006Renewal fee patent year 08
18.12.2006Renewal fee patent year 09
12.04.2007Renewal fee patent year 10
10.04.2008Renewal fee patent year 11
16.04.2009Renewal fee patent year 12
25.03.2010Renewal fee patent year 13
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]WO9222653  (GENENTECH INC [US]) [X] 7,10-13,25-27 * the whole document and specially: see SEQ.ID.N. 17,18 and 25; page 5, line 24 - page 7, line 35 * * page 9, line 22 - page 10, line 4; figure 5 * [Y] 1,4,14,15,22,28-31,34-38;
 [A]GB2268744  (CELLTECH LTD [GB]) [A] 1,32-41 * abstract * * page 4, paragraph 3 - page 6, paragraph 1 *;
 [DY]  - KIM ET AL.,, "Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo", NATURE, London, GB, (1993), vol. 362, page 841, XP002013864 [DY] 1,4,14,15,22,28-31,34-38 * abstract *

DOI:   http://dx.doi.org/10.1038/362841a0
 [A]  - M.M. BENDIG, "Humanization of rodent monoclonal antibodies", METHODS: A COMPANION TO METHODS IN ENZYMOLOGY, New York, NY, US, (1995), vol. 8, pages 83 - 93, XP000647344 [A] 1,34-38 * the whole document *
 [PX]  - M. BACA ET AL.,, "Antibody humanization using monovalent phage display", JOURNAL OF BIOLOGICAL CHEMISTRY, (19970418), vol. 272, no. 16, pages 10678 - 10684, XP002077471 [PX] 1-42 * the whole document *
by applicantUS4485045
 US4544545
 US5013556
 WO9411026
    - CHAMPE ET AL., J. BIOL. CHEM., (1995), vol. 270, pages 1388 - 1394
    - VITETTA ET AL., SCIENCE, (1987), vol. 238, page 1098
    - EPSTEIN ET AL., PROC. NALL. ACAD. SCI. USA, (1987), vol. 82, page 3688
    - HWANG, PROC. NATL ACAD. SCI. USA, (1980), vol. 77, page 4030
    - Current Protocols in Immunology, WILEY-INTERSCIENCE, (1991), vol. 1-2
    - KARLSSON ET AL., METHODS: A COMPARISON TO METHODS IN ENZYMOLOGY, (1994), vol. 6, pages 97 - 108
    - LEUNG, SCIENCE, (1989), vol. 246, pages 1306 - 1309
    - BORGSTROM, CANCER RES, (1996), vol. 56, pages 4032 - 4039
    - CARTER, PROC. NALL. ACAD. SCI. U.S.A., (1993), vol. 89, pages 4285 - 4289
    - BASS ET AL., PROTEINS, (1990), vol. 8, pages 309 - 314
    - LOWMAN ET AL., BIOCHEMISTRY, (1991), vol. 30, pages 10832 - 10838
    - GARRARD, BIOLECHNOLOGY, (1991), vol. 9, pages 1373 - 1377
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.